AXIN1 and hepatocellular carcinoma: Axin and GSK-3β also act to regulate ubiquitin-dependent proteasomal degradation of Smad3 in human keratinocytes and hepatocellular carcinoma cells in a manner analogous to the β-catenin degradation process [71].